Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

被引:41
|
作者
Dilley, James [1 ]
Burnell, Matthew [1 ]
Gentry-Maharaj, Aleksandra [1 ]
Ryan, Andy [1 ]
Neophytou, Christina [1 ]
Apostolidou, Sophia [1 ]
Karpinskyj, Chloe [1 ]
Kalsi, Jatinderpal [11 ]
Mould, Tim [2 ]
Woolas, Robert [3 ]
Singh, Naveena [4 ]
Widschwendter, Martin [11 ]
Fallowfield, Lesley [5 ]
Campbell, Stuart [6 ]
Skates, Steven J. [7 ,8 ]
McGuire, Alistair [9 ]
Parmar, Mahesh [1 ]
Jacobs, Ian [10 ]
Menon, Usha [1 ]
机构
[1] UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit UCL, 2nd Floor, London WC1V 6LJ, England
[2] Univ Coll London Hosp, London, England
[3] Queen Alexandra Hosp, Portsmouth, Hants, England
[4] Barts Hlth NHS Trust, London, England
[5] Univ Sussex, Brighton & Sussex Med Sch, Sussex Hlth Outcomes Res & Educ Canc SHORE C, Brighton, E Sussex, England
[6] Create Hlth London, London, England
[7] Massachusetts Gen Hosp, Boston, MA 02114 USA
[8] Harvard Med Sch, Boston, MA 02115 USA
[9] London Sch Econ, London, England
[10] Univ New South Wales, Sydney, NSW, Australia
[11] UCL, Inst Womens Hlth, London, England
基金
英国医学研究理事会;
关键词
Ovarian cancer; Symptoms; Routes to diagnosis; Survival; UKCTOCS; GOFF index; NICE; PREDICTIVE-VALUE; WOMEN; OUTCOMES; TIME; DELAY; STAGE;
D O I
10.1016/j.ygyno.2020.05.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. There are widespread efforts to increase symptom awareness of 'pelvic/abdominal pain, increased abdominal size/bloating, difficulty eating/feeling full and urinary frequency/urgency' in an attempt to diagnose ovarian cancer earlier. Long-term survival of women with these symptoms adjusted for known prognostic factors is yet to be determined. This study explored the association of symptoms, routes and interval to diagnosis and long-term survival in a population-based cohort of postmenopausal women diagnosed with invasive epithelial tubo-ovarian cancer (iE0C) in the 'no screen' (control) UKCTOCS arm. Methods. Of 101,299 women in the control arm. 574 were confirmed on outcome review to have iE0C between randomisation (2001-2005) and 31 December 2014. Data was extracted from medical notes and electronic records. A multivariable model was fitted for individual symptoms, time interval from symptom onset to diagnosis, route to diagnosis, speciality, morphological Type, age at diagnosis, year of diagnosis (period effect), stage, primary treatment, and residual disease. Results. Women presenting with symptoms listed in the NICE guidelines (HR1.48, 95%CI 1.16-1.89, p = 0.001) or the modified Goff Index (HR1- 68, 95%CI 1.32-2.13, p < 0.0001) had significantly worse survival than those who did not. Each additional presenting symptom decreased survival (HR1.20, 95%CI 1.12-1.28, p < 0.0001). In multivariable analysis, in addition to advanced stage, increasing residual disease and inadequate primary treatment, abdominal pain and loss of appetite/feeling full were significantly associated with increased mortality. Conclusions. The ovarian cancer symptom indices identify postmenopausal women with a poorer prognosis. This study however cannot exclude the possibility of better outcomes in those who are aware and act on their symptoms. (C) 2020 The Authors. Published by Elsevier Inc.
引用
收藏
页码:316 / 322
页数:7
相关论文
共 50 条
  • [31] Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21 715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening
    Fallowfield, L.
    Fleissig, A.
    Barrett, J.
    Menon, U.
    Jacobs, I.
    Kilkerr, J.
    Farewell, V.
    BRITISH JOURNAL OF CANCER, 2010, 103 (04) : 454 - 461
  • [32] Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21 715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening
    L Fallowfield
    A Fleissig
    J Barrett
    U Menon
    I Jacobs
    J Kilkerr
    V Farewell
    British Journal of Cancer, 2010, 103 : 454 - 461
  • [33] Survival of Patients With Mucinous Ovarian Carcinoma and Ovarian Metastases A Population-Based Cancer Registry Study
    Simons, Michiel
    Ezendam, Nicole
    Bulten, Johan
    Nagtegaal, Iris
    Massuger, Leon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (07) : 1208 - 1215
  • [34] Ethnic inequalities in routes to diagnosis of cancer: a population-based UK cohort study
    Martins, Tanimola
    Abel, Gary
    Ukoumunne, Obioha C.
    Mounce, Luke T. A.
    Price, Sarah
    Lyratzopoulos, Georgios
    Chinegwundoh, Frank
    Hamilton, William
    BRITISH JOURNAL OF CANCER, 2022, 127 (05) : 863 - 871
  • [35] Statin use and survival following a diagnosis of ovarian cancer: A prospective observational study
    Majidi, Azam
    Na, Renhua
    Jordan, Susan J.
    De Fazio, Anna
    Webb, Penelope M.
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (07) : 1608 - 1615
  • [36] Use of menopausal hormone therapy before and after diagnosis and ovarian cancer survival-A prospective cohort study in Australia
    Na, Renhua
    Jordan, Susan J.
    DeFazio, Anna
    Williams, Merran
    Livingstone, Karen
    Obermair, Andreas
    Friedlander, Michael
    Grant, Peter
    Webb, Penelope M.
    INTERNATIONAL JOURNAL OF CANCER, 2025, 156 (02) : 280 - 292
  • [37] Metformin use and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada
    Kaur, Paramdeep
    Berchuck, Andrew
    Chase, Anne
    Grout, Bronwyn
    Deurloo, Cindy McKinnon
    Pearce, Leigh C.
    Pike, Malcolm C.
    Richardson, Jean
    Terry, Kathryn L.
    Webb, Penelope M.
    Hanley, Gillian E.
    NEOPLASIA, 2024, 56
  • [38] Pre-diagnosis Cruciferous Vegetables and Isothiocyanates Intake and Ovarian Cancer Survival: A Prospective Cohort Study
    Wei, Yi-Fan
    Hao, Ying-Ying
    Gao, Song
    Li, Xiu-Qin
    Liu, Fang-Hua
    Wen, Zhao-Yan
    Wang, Han-Yuan
    Zhang, Shuang
    Yan, Shi
    Luan, Meng
    Zhao, Yu-Hong
    Gong, Ting-Ting
    Wu, Qi-Jun
    FRONTIERS IN NUTRITION, 2021, 8
  • [39] Beta-blockers and epithelial ovarian cancer survival: A Norwegian population-based cohort study
    Lofling, Leif Lukas
    Stoer, Nathalie C.
    Sloan, Erica K.
    Nafisi, Sara
    Fortner, Renee Turzanski
    Botteri, Edoardo
    INTERNATIONAL JOURNAL OF CANCER, 2025,
  • [40] The effect of waiting time on ovarian cancer survival in oncology centres, Addis Ababa, Ethiopia: a retrospective cohort study
    Habteyes, Abrham Tesfaye
    Deressa, Jembere Tesfaye
    Kassa, Roza Teshome
    BMC WOMENS HEALTH, 2025, 25 (01)